Latest / Psychopharmacology Today / Ep. 10: Medical Cannabis Revisited: What Clinicians Need to Know in 2026
Transcript
- 0:05Medical cannabis has become legal in several states,
- 0:08allowing clinicians to prescribe it.
- 0:10However, studies have demonstrated that prescribers may not
- 0:14be equipped with adequate knowledge to prescribe marijuana products.
- 0:19Even clinicians who are not prescribing still encounter patients
- 0:24who are using marijuana in various forms.
- 0:27Patients additionally have their own expectations,
- 0:30which may or may not be based in the science of cannabis.
- 0:35This seminar tonight will overview the pharmacology
- 0:39and therapeutics of cannabis products,
- 0:41as well as the impact the use of these products may have on the patient,
- 0:46such as drug testing results, employment,
- 0:49and driving. This lecture will also review legal limitations of state cannabis laws.
- 0:54And we're very fortunate this evening to have Dr.
- 0:57Randall Tackett. Dr. Tackett received his PhD in pharmacology
- 1:01and toxicology from the University of Georgia.
- 1:04After completion of a postdoctoral fellowship at the Medical University
- 1:09of South Carolina, he returned to the University of Georgia College
- 1:12of Pharmacy as an assistant professor.
- 1:15He is currently professor and associate department head in
- 1:18the Department of Clinical and Administrative Pharmacy and the Doctor
- 1:22of Clinical Trial Certificate Program in Regulatory Affairs.
- 1:26He also holds adjunct faculty appointments at Alliant University
- 1:31and Fairleigh Dickinson University.
- 1:33He has given numerous lectures about dealing with adverse drug interactions,
- 1:39cardiovascular disease, substance abuse,
- 1:42psychopharmacology, and forensic pharmacy.
- 1:46He is recognized as an expert in both pharmacology and toxicology
- 1:52in the area of substance abuse.
- 1:54And so it is with great pleasure that I
- 1:57turn this over to Dr. Tackett.
- 2:00Thank you, Phil, and thank you everybody for joining us for this webinar.
- 2:03This has ~ been an interesting journey with regard to marijuana.
- 2:08I remember when I was an early assistant professor and marijuana
- 2:12was being discussed about being legalized.
- 2:15I remember saying to myself, "There is no way that marijuana will be legalized
- 2:20in my lifetime." And that just comes back to emphasize why you should never
- 2:24say never.
- 2:25Because it does come back to to get you.
- 2:27There has been a lot of issues that have come up.
- 2:30There's a lot of misperceptions we see with the public.
- 2:34~ There's a lot of people that think that ~ legalization
- 2:38of medical marijuana equates to legalization of marijuana.
- 2:42And there is ~ a lot of issues that are starting to arise.
- 2:47I've given several talks in different states,
- 2:49the medical associations, and one of the things is that
- 2:52the physicians and clinicians that are going to be prescribing this really
- 2:57are somewhat in a void with regard to where they can get it.
- 3:01Some states they've legalized marijuana,
- 3:03but they have not developed the dispensaries and things like that that
- 3:08~ is necessary to give it. So for example,
- 3:10I told one state,
- 3:11"Your issue is, you can prescribe it;
- 3:13the patient has nowhere to get it." And we've even had instances...
- 3:17I know here in ~ in Georgia, I had recently a legal case where a
- 3:22guy had a prescription and bought weed on the street and he tried
- 3:26to convince the officers that he had a prescription and that he gave
- 3:30it to the dealer. And ~ the dealer took his prescription and probably used
- 3:34it for something else.
- 3:35What we're gonna try to do is we're gonna talk about the cannabinoids in general.
- 3:39The other thing you're gonna hear me talk about is there's a lot of concern,
- 3:43a lot of misinformation, ~ a lot of partial information out,
- 3:48because people talk about marijuana,
- 3:51they talk about CBD, other cannabinoids,
- 3:54and so we're gonna we're gonna sort of touch on those.
- 3:56I've used this slide since I've been teaching about marijuana ~ for years.
- 4:01And ~ I sort of like the slide because it sort of represents one of
- 4:06the things that I have seen. Carlini basically made a statement:
- 4:10"Very few drugs, if any, have such a tangled history as a medicine.
- 4:14In fact, prejudice, superstition,
- 4:16emotionalism, and even ideology have managed to lead cannabis to
- 4:20ups and downs concerning both its therapeutic properties and
- 4:23its toxicological and dependence-inducing effects."
- 4:26And that in fact is one of the big issues.
- 4:29One thing that's happened is people have ~ their agendas for pushing marijuana.
- 4:34A lot of people have felt like if we get medical marijuana legalized,
- 4:38that opens the door for recreational.
- 4:40I've had ~ students and healthcare professionals that think that marijuana
- 4:45is legal ~ to use recreationally because it's been legalized.
- 4:49And we have things that the public believes.
- 4:52~ For example, a lot of people say marijuana is safer than alcohol because with
- 4:56marijuana you know just how high you are,
- 4:58whereas with alcohol you don't.
- 5:00A lot of people do not think you can get addicted to marijuana.
- 5:03So there is a lot of misinformation out there and there's a
- 5:07lot of information that's coming out on the internet and through various social
- 5:11media, which really is just misinformation.
- 5:15One of the things when I'm dealing usually with either a legal case
- 5:18or a student issue or something like that,
- 5:20I usually try to find out well,
- 5:21where did you get this information?
- 5:22And it just comes from a number of sources,
- 5:24and AI is adding to it. We're gonna talk about,
- 5:28just in general, marijuana, both from a recreational and medical standpoint,
- 5:32but focusing a little bit stronger on the medical.
- 5:34So when we talk about medical marijuana,
- 5:37one thing that comes into play is that we have to differentiate between recreational
- 5:42and medical. There is the belief that legalization handles both of them,
- 5:47and that's not true. We also have the issue that a person,
- 5:52if they've got a prescription for medical marijuana,
- 5:54they can just get it from somewhere off the street.
- 5:57We now have the gummies, the edibles,
- 5:59which have opened a new door. A lot of states that are trying
- 6:03to legalize medical marijuana are addressing or trying to address the issue with
- 6:07the gummies. We also have the issue of on the street,
- 6:11and even in some of the dispensaries,
- 6:13there can be a wide range of
- 6:16concentration that's available.
- 6:18~ Even in a state like Colorado,
- 6:20I'll show you a slide a little bit later on,
- 6:22where they were getting marijuana from dispensaries,
- 6:25there was a wide range. So one of the things with street marijuana,
- 6:28we do see a really wide range of potency in the different components there.
- 6:33When we're talking about using any drug,
- 6:36and this includes marijuana, we often have to make an issue of benefit versus harm.
- 6:42So there's still this risk assessment.
- 6:44And so a clinician that is going to be prescribing marijuana needs
- 6:49to really assess the benefit versus the risk.
- 6:53And part of that benefit is going into the potential side effects.
- 6:57And one of the big things that I have seen,
- 6:59especially over the last three or four years,
- 7:01some of this harm situation may come into place with regard to driving issues,
- 7:07maintaining your job,
- 7:08the problematic issue of failing a drug test.
- 7:11The other thing that complicates things is each state is developing their
- 7:15own laws and their own legal restrictions,
- 7:18and those can differ from federal.
- 7:20So one of the things we're running into and have run into since
- 7:23the very early beginning is a prescription in one state may not
- 7:27be recognized in another state.
- 7:29So these are all issues that have created a lot of problems when you opt
- 7:35to potentially use marijuana.
- 7:37The other thing that's happened is so marijuana,
- 7:40the legal thing sort of took a back seat and we saw the other cannabinoids move
- 7:45to the front. And you're going to see me talk about this several ways.
- 7:49We have what is referred to at one time the "CBD Wave," and CBD is ~ cannabidial,
- 7:56so we'll refer to that as CBD.
- 7:58This is considered the "safe" marijuana,
- 8:01~ the "safe" cannabinoid, if you will.
- 8:04But here's the problem: A lot of CBD is in over-the-counter products.
- 8:10There is estimated, this is an old estimate,
- 8:12and I would say that it probably exceeds this now,
- 8:15but it's been estimated that there's clearly over at least a thousand
- 8:20CBD products that are being sold through internet,
- 8:23dispensaries, pharmacies, retail stores.
- 8:27I mean, one of my students failed a drug test because they got CBD
- 8:30that came from ~ Tractor Supply.
- 8:33~ I've seen some of the individuals are buying it for their pets and using
- 8:37it too from pet stores. Been a lot of media coverage.
- 8:40And the other thing with marijuana and the cannabinoids in general
- 8:44is there's this perception that this can be used to treat everything and that it's
- 8:49a natural product and it's very safe.
- 8:51In fact, one of the things
- 8:52that I've had some people that are really pushing strong
- 8:55for legalization of marijuana cite things that there are more side effects
- 9:00associated with taking ~ a common aspirin than you get with marijuana;
- 9:05that's misinformation. Okay? ~ Big business,
- 9:08a lot of companies are moving offshore.
- 9:10It probably exceeds a $60 billion market value.
- 9:15So it's very lucrative.
- 9:17And that's one of the things that has pushed CBD and marijuana.
- 9:23And a lot of times they sort of get ~ mixed by referred to as cannabinoids.
- 9:28One of the things that we found is when CBD and the cannabinoids
- 9:32and medical marijuana or marijuana came up,
- 9:35is one of the things that's been sort of a barrier has been it's a Schedule
- 9:39I in many states. Federal government classifies it as a Schedule I drug.
- 9:44And I know as a scientist, when we're doing studies in Schedule I drugs,
- 9:47we have a lot more barriers and things,
- 9:50regulations that we have to follow,
- 9:52which makes it more difficult to work with.
- 9:54It's not that it can't be overcome,
- 9:56but basically ~ it makes it more difficult.
- 9:59The other thing is what we're seeing on the street may differ between what
- 10:05we get from the National Institute on Drug Abuse,
- 10:07NIDA.
- 10:09When we first started a few years ago when we looked at CBD alone,
- 10:14cannabidiol, there was only twenty-one published studies that came out.
- 10:18And and this stuff has been around for a long time.
- 10:20And the other thing is if you look at the literature associated with
- 10:25the effects of marijuana, ~ a lot of times we didn't know exactly how much
- 10:31of the other cannabinoids were there.
- 10:32But nevertheless,
- 10:34what we've seen is, especially CBD,
- 10:37has been sort of this cannabinoid that's moved in because it's more legal
- 10:42and people have started using it.
- 10:44And so a lot of people who are not getting medical marijuana may start using CBD.
- 10:49And when you look at it, one of the things you see,
- 10:52looking on social media, the internet,
- 10:54and so forth, and even in the literature,
- 10:56one of the things that's coming out about not only marijuana but CBD,
- 10:59is that these...
- 11:02the states are even listed, and this is approved for these certain diseases.
- 11:05And some of the data for these particular diseases ~ is really,
- 11:09really weak. For example, if you look at the conditions that it has been cited
- 11:15to treat or advocated for treatment:
- 11:18anxiety, cannabis use disorder,
- 11:20Crohn's disease, diabetes, epilepsy,
- 11:23Huntington disease,
- 11:25Parkinsonism, opioid use disorder,
- 11:27schizophrenia and psychosis, autism,
- 11:30cancer, sleep disorders, pain.
- 11:32So there are some studies that suggest that the cannabinoids may have a benefit.
- 11:38~ There's a lot of work that's being done looking at
- 11:42the different individual cannabinoids and maybe trying to tease it out.
- 11:45But with many herbal-type preparations,
- 11:49which we would consider marijuana sort of an herb,
- 11:52there's a mixture.
- 11:53There's a mixture of components that are there.
- 11:55And so you may or may not know what you're getting.
- 11:59And so trying to get pure CBD,
- 12:03and some of the studies have used a commercially available CBD,
- 12:06which may not be completely pure,
- 12:08has created a lot of problems in trying to sort this out.
- 12:13So if we look at sort of a broad spectrum,
- 12:16and this is not everything, if you look at the cannabinoids,
- 12:18your body makes endocannabinoids.
- 12:20One of the reasons people
- 12:22~ cite that marijuana is safe is your body makes them.
- 12:25Okay? They're actually derived from a substance many of you may be familiar with:
- 12:29arachidonic acid. Arachidonic acid is a precursor to a number of substances,
- 12:34including prostaglandins and so forth.
- 12:36And the endocannabinoids are considered sort of an endogenous modulator
- 12:40~ and interacts with a number of transmitters and modulates those.
- 12:46So there is no wonder that some of the pharmacological
- 12:49and toxicological effects that we're seeing
- 12:52would be associated with this.
- 12:53The phytocannabinoids, these are the ones that we have the most ~ publicity about,
- 13:00most people are familiar with.
- 13:01The phytocannabinoids, there are a number of naturally occurring compounds
- 13:06in cannabis sativa. And there's various different forms of cannabis.
- 13:11In fact, here in the southeast,
- 13:13several years ago there was a botanist that made a lot of money going around when
- 13:18people had been
- 13:19arrested for having cannabis, he would go and say it was a different form
- 13:23of cannabis that didn't have the psychogenic properties.
- 13:27But the phytocannabinoids include THC,
- 13:31cannabinol, and cannabidiol. And then the last one here that I got listed
- 13:36are the synthetic cannabinoids.
- 13:37These are produced- actually they're congenitors of either THC or cannabidiol.
- 13:44~ One of our legal prescriptions that we have,
- 13:47it's called Marinol, is actually a synthetic cannabinoid.
- 13:51But we also see some of these synthetic cannabinoids are made
- 13:55by clandestine labs and, again,
- 13:58can be pretty nasty. And in fact,
- 13:59one of the things that we have seen is in certain states where marijuana
- 14:05was legalized or medical marijuana was legalized,
- 14:08people have taken synthetic cannabinoids.
- 14:11And their concept is sort of like,
- 14:13well, it's a cannabinoid, it was just made in the lab rather than the plant.
- 14:16And some of these synthetic cannabinoids have some pretty toxic effects.
- 14:20For example, in Colorado, we saw an increase in ER admissions ~ with
- 14:25the use of synthetic cannabinoids once ~ marijuana had been legalized
- 14:30~ for medical purposes.
- 14:32So just as a quick review, the THC.
- 14:34we usually refer to this as THC Delta-9.
- 14:37It is sort of the main component in marijuana.
- 14:41It produces the psychoactive effects.
- 14:44It is responsible for the euphoria.
- 14:46~ I've got increased reaction time,
- 14:49meaning that it
- 14:50takes you longer to respond. People have loss of memory,
- 14:54may have cognitive ~ functioning episodes.
- 14:58It is usually cleared from your blood pretty quick.
- 15:00Now it varies a lot, so we've got mixed information,
- 15:03but the half-life from your blood is roughly about 30 minutes,
- 15:07but it can be longer, and it can be detectable in blood urine.
- 15:10Okay. So if we see Delta-9 THC,
- 15:13that is a concern
- 15:15and usually means the individual has taken ~ marijuana and has the psychogenic.
- 15:22Now you will hear me talk about Delta-8 and Delta-10 THC,
- 15:25which has created another problem which we'll address very shortly.
- 15:29CBN is cannabinol. Cannabinol is of very good interest
- 15:35to drug companies. ~ It's been shown to be an analgesic so it relieves pain.
- 15:41~ It helps people sleep. Actually,
- 15:43there's some studies in vitro showing that it can promote ~ healing,
- 15:47that bone cells are grown. It has some antibacterial properties,
- 15:51maybe anti-inflammatory, can be an appetite stimulant.
- 15:55So there's a lot that pharmaceutical companies are interested in with cannabinol.
- 16:01~ You can think of several instances with how this works,
- 16:05how it could be a pharmaceutical.
- 16:07And then we have CBD, which is really the one that has come on strong.
- 16:12And the thing about CBD is that it can actually modify the effects
- 16:17of the Delta-9 THC. ~ One of the things it can do
- 16:22is THC gets broken down in the body by the cytochrome P450 system,
- 16:27and it gets broken down ~ to 11-hydroxy-THC.
- 16:32And 11-hydroxy-THC is
- 16:34an active metabolite of THC. We don't get CBD forming from
- 16:39THC because it doesn't form by the heat from smoking
- 16:45or by metabolism. But the thing about CBD is that it actually may have some of the,
- 16:51it may antagonize some of the effects of THC,
- 16:55which may be good.
- 16:56And in fact, a lot of states, their laws are saying that medical marijuana should
- 17:01be about 50-50. In other words,
- 17:03you should have about 50% CBD and 50% Delta-9.
- 17:07And the reason for that is the CBD will mitigate some of the side effects
- 17:13of the THC. And then this other one I've just mentioned,
- 17:16because it shows up on drug tests a lot,
- 17:19is the tetrahydrocannabinol carboxy metabolite.
- 17:23This is the metabolite that stays around in the body's fat.
- 17:28A lot of times when people get tested for marijuana,
- 17:31it will pick up the THC carboxyl in urine or in blood
- 17:37and even hair, and it will stay around for a while.
- 17:40So if someone tests positive on a drug test,
- 17:44the first thing we want to know is did the drug test detect
- 17:49THC carboxyl, or did it detect Delta-9 or one of the other cannabinoids?
- 17:54Many times the screening tests that you see in hospitals
- 17:58and employment will primarily pick up the THC.
- 18:01And basically, you can't relate a THC carboxyl level back
- 18:07to level of impairment. But it does indicate that someone has been exposed
- 18:13or ingested ~ marijuana.
- 18:16Now, the other thing that's been,
- 18:17there has been significant research done is we do know there
- 18:20are cannabinol receptors, okay?
- 18:23As a pharmacologist, we often look to see where the receptors are.
- 18:26If the receptors are there, that gives us an idea that the drug can act there.
- 18:30So you see on this slide here,
- 18:33we find that there is ~ receptors in the cerebellum,
- 18:37and this would explain cannabinoids' effect on movement.
- 18:41In the basal ganglia, another area involved with movement.
- 18:44The cerebral cortex, that would explain some of the effects on cognition.
- 18:49The hypothalamus; that explains the effects of appetite,
- 18:54"the munchies." The hippocampus is going to describe or basically explain
- 18:59why we see that marijuana may affect learning,
- 19:02memory, or the stress reaction.
- 19:04In the medullary area, there is nausea and vomiting in the chemoreceptor zone,
- 19:08which most of you are aware of.
- 19:10A big push for getting marijuana legalized was to use it as an antiemetic,
- 19:15especially for cancer patients.
- 19:17And we also see that there's ~ CB receptors in the spinal cord.
- 19:21And this has been an area that ~ a lot of drug companies have been interested
- 19:25in because the idea would... ~ this may be a site of action
- 19:29where drugs could potentially ~ be beneficial for spastic disorders
- 19:35and potentially pain.
- 19:36As you can see, ~ these different receptors in the frontal cortex,
- 19:41basal ganglia, hippocampus, and the central nervous,
- 19:44all these sites, you know, pleasure,
- 19:46movement, learning, memory, pain.
- 19:48We also see that the CB receptors are in the mesolimbic reward center.
- 19:54This would explain the reinforced pleasurable activities.
- 19:58It would explain
- 19:59the addiction potential for these drugs.
- 20:01In the cerebellum and basal ganglia,
- 20:03as I just said, the negative aspects of this is it will account
- 20:07for the person having problems with coordination,
- 20:09being extremely clumsy, having difficulty,
- 20:12and that's especially for recreational users.
- 20:14But from a positive standpoint,
- 20:17these receptors in the cerebellum and basal ganglia may be very important,
- 20:22and marijuana
- 20:23or cannabinoids may be important for treating the spasticity,
- 20:27~ especially in these upper motor neuron diseases such as multiple sclerosis.
- 20:33So again, like most drugs, there's a good and bad sort of a,
- 20:37you know, Dr. Hyde situation that we've got dealing with it.
- 20:40Okay? Hippocampus, modulate mood.
- 20:43We do see people's mood can go up and down.
- 20:45Now most people, their perception is marijuana is going to put them in a good mood.
- 20:51You know, a very chill mood. It's not everybody.
- 20:53So this mood can go either way.
- 20:56Most people are thinking it's gonna chill people out,
- 20:58but sometimes we can have just the opposite effect.
- 21:01A big concern we have is, whether this is medical or recreational,
- 21:06is what's happening with the prefrontal cortex and the hippocampus,
- 21:10because we're concerned about it influencing or affecting a person's concentration,
- 21:15their short-term memory,
- 21:17their ability to maintain attention,
- 21:19their tracking behavior, especially when you're looking at someone driving
- 21:23or doing some sort of ~ work that requires them to follow things.
- 21:26And ~ then the hypothalamus, interestingly,
- 21:29most people are familiar with marijuana producing the munchies.
- 21:32We've actually seen that that is one of the things that we've used marijuana
- 21:36for is in these wasting diseases,
- 21:38~ stimulating appetite, ~ that can sometimes help quite a bit.
- 21:43And then again, in the spinal cord,
- 21:45the real concern and real interest there is how these may modulate central pain
- 21:51pathways and be a good analgesic.
- 21:54You know, a lot of people are thinking,
- 21:56all right, marijuana or these cannabinoids may be a better alternative than opioids
- 22:00or can be used to reduce the amount of opioids.
- 22:03So that's one of the big things that's being considered.
- 22:05This dopaminergic pathway, as I mentioned earlier...
- 22:09One of the things that we find is a lot of people believe that
- 22:12you can't get addicted to marijuana.
- 22:14Part of that is, I think, some PR to promote the ~ approval of marijuana.
- 22:20Another of it sometimes is people may use it occasionally and so may not
- 22:26be using it on a regular basis.
- 22:27So ~ the idea is that people can't abuse it.
- 22:31And the other thing is sometimes we see marijuana-
- 22:33when somebody checks in for abuse or a substance abuse issue,
- 22:37marijuana is one of many drugs and most people are focusing on the other drugs
- 22:42and not really thinking of marijuana being the substance that's really abused.
- 22:47But we do see there's a significant number of people that actually check into
- 22:52substance abuse programs ~ specifically for marijuana alone.
- 22:57So we do know there is an abuse and dependence potential with marijuana.
- 23:02Now this last statement I have on this slide is interesting because many people make
- 23:07the case that no one has ever died as a result of marijuana overdose,
- 23:12okay? And that's why I have this statement:
- 23:15"no known lethal overdose." And a lot of that is because it
- 23:19is believed marijuana has very minimal effects
- 23:22on the autonomic nervous system,
- 23:23that there are very few receptors in the brainstem.
- 23:26I will tell you that we now have one reported incidence
- 23:32of marijuana overdose. It was published in The New England Journal of Medicine.
- 23:36And, granted, it was a person used huge amounts of marijuana,
- 23:42but we do have a documented overdose due to that.
- 23:47So again, if you say it's never going to do it,
- 23:49there's always someone that's going to show you differently.
- 23:52Now, another thing that creates problems is when we look at
- 23:57the various cannabinoids that are present.
- 24:00One of the things I always tell people is that when you're growing plants
- 24:04and you're looking at compounds,
- 24:05and I've done a number of bench studies on different
- 24:08compounds and ~ herbal medicines and things like that.
- 24:12One of the things that's going to occur is when you're growing a plant,
- 24:15the actual concentration of the different constituents is going to vary based upon
- 24:22the growing conditions. The example I use,
- 24:24I'm sitting here in my my office at my house and I'm looking out
- 24:27at our small garden, and I love growing peppers.
- 24:30I should say my wife grows those and I love eating the peppers,
- 24:33but... jalapeños.
- 24:36So if I take and I really, really water the jalapeño peppers ~ a lot,
- 24:41I mean just a lot, the pepper will grow and it'll be a very mild pepper.
- 24:48However, if it's a drought and I'm not watering as much,
- 24:52the pepper still grows, but it gets really concentrated.
- 24:55So depending on my growing condition,
- 24:58~ the amount of capsaicin, which is the,
- 25:01you know, heat forming component in peppers,
- 25:03can vary.
- 25:04Same thing with marijuana. But in the raw plant,
- 25:07we have THC A and we have ~ CBD;
- 25:12these are acids and CBC. And some of those may have their own ~ actions
- 25:19~ with themselves, but when they get heated,
- 25:22they get converted to THC and CBD and CBC and CBG.
- 25:29And then even when ~ the marijuana gets aged,
- 25:33we see some different changes.
- 25:34And one of the things we found is,
- 25:37and I'll point this out shortly,
- 25:38is Delta-8 THC... in some of the plants,
- 25:43we don't have a lot of Delta-8,
- 25:45but in what's being sold over-the-counter,
- 25:47quote, legally, has been reinforced with a lot of Delta-8.
- 25:52And so
- 25:53the nature of the marijuana can differ not only in the amount,
- 25:58but also in the specific constituents that's there.
- 26:02So that's a very important thing,
- 26:03especially if you're prescribing,
- 26:05the question really becomes, you know,
- 26:07what am I prescribing? Cannabinoids are not new in our medical situation.
- 26:11We have some that are medically available.
- 26:14The one we've had around for a long time is Marinol,
- 26:17which is dronabinol. We also have nabilone and
- 26:21fairly recently, we had the release of Epidiolex,
- 26:25which is a CBD. ~ Canada's had nabiximols and Europe had one called rimonabant.
- 26:32That one was actually tried to get approved in the United States,
- 26:35but was not approved by the FDA ~ because of the concerns of depression
- 26:40and suicide in some of the clinical trials.
- 26:43So if you look at dronabinol, and this is what I tell my students all the time:
- 26:46If marijuana was as good as everybody says it is,
- 26:49I mean, we've had Marinol around since '85.
- 26:51To my knowledge, it's never been a top-300 drug.
- 26:55Okay? It's a Schedule III. ~ It's actually a synthetic form of THC.
- 27:01And it was approved for use for nausea and vomiting that occurred during
- 27:06chemotherapy. It also has been approved for ~ treating AIDS
- 27:11because of the anorexia and the wasting.
- 27:12So the Marinol actually will stimulate the appetite.
- 27:17Nabilone was another synthetic one,
- 27:19same indication as dronabinol.
- 27:21What you really see between these two is really a little difference between onset
- 27:28and duration. So dronabinol kicks in over 30 to 60 minutes,
- 27:33lasts up to six hours. Nabilone kicks in 60 to 90 minutes,
- 27:37lasts up to twelve hours. As far as therapeutically as an antiemetic,
- 27:41it's about the same,
- 27:42and actually pretty close to what we saw with some other drugs we used
- 27:46for treating nausea, the phenothiazines.
- 27:48What we did see is that when a person started with these drugs,
- 27:52that especially in a naive person,
- 27:55we had to be careful because they would experience the euphoria or dysphoria,
- 27:59cognitive clouding, drowsiness and dizziness.
- 28:03And then as they used it more and more,
- 28:05then they would sort of develop a tolerance to that.
- 28:07So when a person was first starting it,
- 28:09this was more of a problematic issue.
- 28:11What we found with these two drugs,
- 28:13which created some problems, you know,
- 28:15with them as far as drugs, is again they ~ went through first pass effect,
- 28:20so they're metabolized fairly quickly.
- 28:21Different levels of absorption that vary between individuals so the blood levels
- 28:26are somewhat unpredictable.
- 28:28But we had a new drug that moved into the market,
- 28:31and that's ondanestron, which was originally marketed as Zofran.
- 28:35And these act on the serotonin receptor,
- 28:38they're actually serotonin receptor antagonists,
- 28:41and these actually are much more potent,
- 28:43they're more predictable, don't produce the psychotropic effects that
- 28:47we see with dronabinol or nabilone,
- 28:49and we could give them IV because previously we did not have
- 28:53a way to give IV dronabinol or nabilone.
- 28:55What we found was these drugs,
- 28:57dronabinol and nabilone, moved to the second and third round.
- 29:00They were hardly ever used as a first line agent.
- 29:03And what we used them is if the other drugs didn't work,
- 29:07then we would try it. So again,
- 29:09this concept that marijuana is going to treat all of these things better than what
- 29:14we have has just not panned out like people have said it would be.
- 29:18Now, I mentioned cannabidiol earlier,
- 29:21and this is sometimes referred to as the other cannabinoid that
- 29:25is present in botanical preparation.
- 29:28So it's the phyto cannabinoid.
- 29:30The big thing about CBD is that it's not psychoactive,
- 29:34okay? But in fact, it may actually mitigate anxiety and paranoia that
- 29:41can be caused by THC. Now, that's something I found out,
- 29:44a lot of people do not think
- 29:46that THC produces anxiety or paranoia.
- 29:48Their concept is, because all the media and everybody that talks about it is,
- 29:52you smoke some weed and you sort of chill out,
- 29:54okay? But what we found is that this may mitigate it and
- 29:58may actually work synergistically in a positive manner with THC.
- 30:02CBD may actually be anxiolytic and may even have some antipsychotic properties.
- 30:07And in fact, over-the-counter CBD supplements,
- 30:11they will suggest that these things are calming agents.
- 30:14Keep in mind a supplement can't say that this is being used to treat anxiety
- 30:19or you know psychosis, but it can say "may reduce stress." But the other thing about
- 30:24CBD, and this resulted in the epidiolex being approved,
- 30:28is that it had some anticonvulsant and neuroprotective effects
- 30:33and actually was effective in some severe forms of spasticity.
- 30:37So if we look at comparing THC and cannabinol,
- 30:41so when I'm talking about THC,
- 30:42I'm primarily talking about Delta-9.
- 30:44Delta-9 will produce the euphoria,
- 30:46the anxiety, the psychosis, the cognitive impairment,
- 30:49and it'll actually stimulate appetite.
- 30:52CBD doesn't produce the euphoria.
- 30:55Now, maybe in real high doses,
- 30:57we may see some, but it tends to be anti-anxiety,
- 31:00antipsychotic, doesn't produce the cognitive impairment.
- 31:04Again, higher dosages, we may see it.
- 31:06And that's one of the basis for why a lot of states want CBD to
- 31:11be at approximately fifty percent of the medical marijuana.
- 31:15Now, a couple of things is Nabiximol is one that's being looked at.
- 31:18~ It was ~ approved in Canada.
- 31:21~ US has tried it in some trials.
- 31:24I don't think this has made it to there.
- 31:25But it's been used for neuropathic pain and cancer pain.
- 31:29But here's what I wanted to point this out.
- 31:31And this is one of the reasons I put nabiximol in here.
- 31:34So it's actually available in Canada as an oral spray.
- 31:39And notice the concentration, it has 2.7 milligrams of
- 31:43Delta-9 THC and two and a half milligrams of CBD.
- 31:47So it's about 50-50. It kicks in pretty quick,
- 31:50doesn't produce the sedation, doesn't produce the memory impairment.
- 31:53And the other thing, which is impressive is when you look
- 31:56at the peak concentrations, they're about 20 times lower than someone would
- 32:01get if they were smoking marijuana.
- 32:04And the idea is the lower THC levels
- 32:07would reduce the potential for dependence.
- 32:09So, this is part of the research that has promoted the addition of
- 32:15CBD in with THC. I've mentioned epidiolex,
- 32:18and the interesting thing about epidiolex is that it's actually a purified form
- 32:24of CBD that was derived from plants.
- 32:27This was actually the first FDA plant-derived CBD product.
- 32:32It's approved, it's indications are very,
- 32:34very slim. It's indicated for severe forms of epilepsy.
- 32:37It was originally approved as a Schedule I,
- 32:40but as most of you know, a C one or a Schedule I drug has no medical use,
- 32:44so you can't approve a drug to use medically and still call it a C one.
- 32:48But what happens is they classified it or reclassified it to a Schedule V.
- 32:53Now, interesting with epidiolex,
- 32:55the FDA-approved warning
- 32:57lists a possible positive drug test.
- 33:00So that is a concern. And it specifically advises
- 33:06the clinician to advise the patient that you may potentially test positive
- 33:10for a cannabis drug test. And that's going to be,
- 33:12that would be important. Now, the people that this was approved for,
- 33:17usually the type of epilepsy and seizures that they have
- 33:21is not going to be a person that is going to typically drive.
- 33:25I met with one of the reps and she said,
- 33:26"Well, we don't really worry about it because most of these people are
- 33:29too sick to drive. So we don't have to worry about the drug testing."
- 33:31But they still need to be tested or be aware of that.
- 33:36Now here's an interesting thing.
- 33:37Some of you may have heard of 2018 Farm Bill.
- 33:40So as we were trying to
- 33:42get more research on marijuana,
- 33:45one of the things was happening was who grows it.
- 33:48In fact, right now in the United States,
- 33:51as far as who is able to grow marijuana,
- 33:54if I ordered some marijuana to do research from the National Institutes
- 33:58of Drug Abuse, the University of Mississippi has got the contract to grow marijuana.
- 34:03The question is, is the marijuana that they grow in their fields under
- 34:07well-controlled growing conditions that
- 34:10may be different than what we see on the streets,
- 34:13okay, just with constituents and other things.
- 34:15But anyway, what they did was to try to get like CBD and things like that.
- 34:20They passed this Farm Bill in 2018,
- 34:23which excluded hemp and derivatives of hemp from a Schedule I listing,
- 34:29okay, which allowed farmers to produce industrial hemp.
- 34:33And as a result of that, that was a pretty good product and cash crop.
- 34:39And it ended up developing a surplus of hemp.
- 34:42Now the other thing is that in order to meet this farm bill's regulations,
- 34:46the cannabis plants had to contain less than 0.3% Delta-9 THC.
- 34:51And if that's the case, then their products were no longer scheduled products.
- 34:56And that included CBD, Delta-8,
- 34:58and Delta-10 THC and also another one,
- 35:00tetrahydrocannabinol O acetate.
- 35:03We've talked about CBD and I've mentioned briefly Delta-8 and Delta-10.
- 35:07So keep that in mind. Now let's move to CBD products back,
- 35:11move back there a little bit. There was a recent article in the Journal
- 35:14of American Medical Association.
- 35:16And one of the things is we had a lot of people that started using CBD.
- 35:21It was sort of like the non-marijuana marijuana.
- 35:24This JAMA article, what they did was they actually went online
- 35:28and they purchased ~ 84 CBD products ~ from 31 different distributors.
- 35:35So a good cross section there.
- 35:36And then they analyzed them. And what they found was 70% of the products,
- 35:41the level of CBD differed from what was on the label.
- 35:44So in other words, what they were advertising was the amount of CBD,
- 35:48that wasn't the amount there. Half of those products,
- 35:51there was more CBD than indicated.
- 35:53A quarter of the products had less CBD.
- 35:55So again, you don't know what you're really buying.
- 35:58It has CBD in it, but you don't know how much.
- 36:01And that's sort of like, you know,
- 36:03somebody giving you a prescription going,
- 36:04"So here's some Lexapro. I'm not sure really how much is in it,
- 36:07but let's see if it works." The thing that was scary is in 18 of the samples,
- 36:12there was actually Delta-9 marijuana,
- 36:14Delta-9 THC. There was a concern with the epidiolex
- 36:19about off-label use of that prescription drug.
- 36:22But I will tell you that, you know,
- 36:24that that drug is around $3,000 a month.
- 36:26And a lot of times they felt like that's gonna be more than someone would pay for.
- 36:30That's just what the drug reps had told me.
- 36:32So how safe is CBD? I mean it's an over-the-counter product and you
- 36:36can buy it legally. My biggest concern with a lot of this is literally
- 36:40the situation of how much are you getting?
- 36:43You know, actually
- 36:44what am I getting and how much am I getting?
- 36:45Our clinical data, they don't do clinical studies on supplements.
- 36:50Okay, very few studies on supplements.
- 36:52That's one of the things we're doing.
- 36:53So a lot of our data actually came from epidiolex,
- 36:57which when it went through its things.
- 36:59But the epidiolex was a highly purified and very well identified subject
- 37:06there.
- 37:07What we did see in the clinical trials with epidiolex was basically
- 37:13we saw some liver enzymes go up.
- 37:15~ We saw the metabolism went through 3A4.
- 37:19~ We did see at high doses there may be an increased risk of sedation or drowsiness,
- 37:24especially when combined with other CNS depressants.
- 37:27But we still have a lot of concerns with regard to this.
- 37:32Now I mentioned Delta-8 earlier.
- 37:34So Delta-8, typically in the legal hemp plants that can be grown according
- 37:39to the 2018 bill, those ~ 2018 products basically
- 37:46what we find is that there's very,
- 37:48very, very low levels of Delta-8 in it.
- 37:51So Delta-8 can actually be synthesized from CBD.
- 37:55So we actually, because of the 2018 Farm Bill,
- 37:59what we ended up getting was we got a lot of CBD,
- 38:03which then was being converted to Delta-8.
- 38:06And then what was happening was manufacturers were taking the Delta-8
- 38:11and adding it back to edibles and other products,
- 38:14inhalation that people would vape and things like that.
- 38:17So ~ what we found was the plant material that had low Delta-8
- 38:22and Delta-9 THC were actually being laced with synthetic Delta-8.
- 38:27And that was a big concern. And the reason it was a concern is because when
- 38:33you look at Delta-8, it has some psychogenic properties.
- 38:36And in fact, the FDA actually
- 38:38put out a warning ~ that said Delta-8 products have not been evaluated
- 38:43or approved by the FDA. ~ The FDA considered them supplements and they
- 38:48had concern over the variability in the product formulations.
- 38:51And they're saying these may be marketed as hemp products.
- 38:54There were adverse events that were reported and ~ the Delta-8
- 38:59has psychoactive properties that are similar to Delta-9.
- 39:02And we also saw that
- 39:04the synthesis of the Delta-8 introduced toxic chemicals into those products.
- 39:09What we found is the Delta-8 is less potent and has a shorter duration
- 39:14of action than Delta-9, sort of a dose related.
- 39:17But what's happening is they're putting a lot of Delta-8 into some
- 39:22of these products. And so even though it's less potent and doesn't last as long,
- 39:26when you elevate the amount into these products,
- 39:30edibles and things like that,
- 39:31it can be very significant. And in fact,
- 39:33I'm seeing more and more with drug tests and driving and things like that,
- 39:37that the crime labs are breaking it down and I'm seeing people that have taken
- 39:42gummies and they have Delta-8,
- 39:43Delta-9, and Delta-10 all in there.
- 39:46There's also another component that gets added in here,
- 39:51~ gets produced, and that's the tetrahydrocannabinol,
- 39:55which is actually more potent than Delta-9.
- 39:58And when it gets heated,
- 39:59it actually releases a very toxic ketene gas.
- 40:03With every drug, all of them will have
- 40:05contraindications, okay? And when you look at the products that are out there,
- 40:09the recommendation is that there are certain conditions that a lot
- 40:14of the medical marijuanas are putting as ~ contraindications.
- 40:18In other words, they assess that the risks over or outweigh the benefits.
- 40:23And of course, with every drug,
- 40:25hypersensitivity is one. But there are also most states
- 40:28are including it's contraindicated under the age of 25.
- 40:32There's a history of psychosis or schizophrenia.
- 40:34If there's a past history of cannabis use disorder or an active substance
- 40:39use disorder. They even list ~ significant cardiovascular pulmonary disease.
- 40:44And also it's contraindicated in women that are pregnant
- 40:48or breastfeeding because that can cross the placenta and can also cross through
- 40:53the mother's milk.
- 40:54Now, we gained a lot of information when Colorado legalized marijuana.
- 40:58And one of the things is they started looking back at that.
- 41:01Someone did an analysis in 2015.
- 41:04So a lab basically went to certified growers and sellers,
- 41:08got 600 samples of bud, and what they found was that
- 41:13the average THC level, we're talking Delta-9 level,
- 41:17was about 18.7%.
- 41:19But in some retails, we actually saw that the THC was greater than 30%.
- 41:25So a big variation. We also saw that there was little or no cannabidiol,
- 41:29CBD. Averaged only about 0.1%.
- 41:32Remember, a lot of states want about 50-50.
- 41:35So we saw a lot of variations,
- 41:37and these were from the government-approved dispensaries.
- 41:41The other issue that comes into play when we look at recreational versus medical
- 41:45use, there's a different way that you use it.
- 41:46The safest way that people will usually say or easiest way
- 41:49to administer marijuana is by smoking it.
- 41:52That is difficult. If any of y'all dealt with people with inhalers,
- 41:56we have to often teach people how to use inhalers properly.
- 41:59So if someone was smoking, we have to frequently make sure they know how to smoke.
- 42:04~ Now, the edibles have come into a new ~ easy way of doing it,
- 42:09but it's created its own problems.
- 42:10But the other thing is in recreational marijuana,
- 42:13what you buy off the street, a lot of different impurities.
- 42:16There's been plenty of studies demonstrating all of the impurities.
- 42:19And not only are the impurities being demonstrated,
- 42:22but we find that they can produce pulmonary lung cancer and things like that,
- 42:26just like cigarettes did.
- 42:27So when we are using these plants,
- 42:30a big concern we have is the dose can vary due to the concentration in plant.
- 42:35Look at what we saw in Colorado.
- 42:36The ratio of THC and CBD varies.
- 42:40~ This can vary according to geographic region,
- 42:43where it comes from. Some people have said,
- 42:45"Well, we'll get around this. Let's adopt a central source
- 42:47of cannabis." Nobody's agreeing to that.
- 42:50We also, when this comes in, there has to be adequate monitoring
- 42:54and prevention of addiction. Those programs have to be put into place.
- 42:57And we are just now getting results of has there been an increase,
- 43:02a decrease in drug use and so forth.
- 43:05So we're just now going through that data.
- 43:07Some of the stuff that's come out now is very early on and we need
- 43:11a little bit longer time. We also see with cannabis,
- 43:14there's always the possibility of contaminants.
- 43:16We find various
- 43:17bacteria and fungi, heavy metals.
- 43:20On the street, people sell it by the bag and people will put glass beads
- 43:26and sand in the street cannabis to increase the weight,
- 43:29which can, you know, create a problem by causing damage to the lungs when
- 43:34you inhale those things. We know THC and these other components actually will
- 43:39affect neurotransmitters and we know there's data in vitro that show that
- 43:42it can affect cell growth. We know that they're fat-loving compounds,
- 43:46they're lipophilic compounds, so they can stay in the body for weeks,
- 43:49especially when people are smoking a lot.
- 43:52We know that even in maternal tissues,
- 43:55some of the studies in dogs is the maternal tissues actually served as reservoirs.
- 44:00So the drug ~ accumulated in there and then was slowly released.
- 44:04And we know it crosses the placenta.
- 44:05So there is big concerns with regard to medical marijuana and marijuana
- 44:11use in general. We know today what's on the street,
- 44:13significant increase from what we saw back in the 70s.
- 44:16It's estimated that we're probably looking at up to a 25-fold difference
- 44:21in concentration. I just read an article where
- 44:23~ pregnant women are smoking or vaping more marijuana and actually drinking more
- 44:28than what we used to do. And THC and these cannabinoids can interfere with folic
- 44:33acid, can affect the fetus that way.
- 44:35And we've seen some mouse studies that have demonstrated that this
- 44:39can create problems with fetal development.
- 44:42In Colorado, this I mentioned earlier today,
- 44:45is that we saw once marijuana was legalized,
- 44:47we saw increased hospitalizations.
- 44:49Patients showed up in the ER and they were hallucinating severely,
- 44:55didn't have a gag reflex, had difficulty breathing.
- 44:57And these were synthetic THC, which were ~ the products that they were using were
- 45:02called "botanical sachet," "sexy monkey," and "crazy monkey."
- 45:06And these were actually, you know,
- 45:08promoted as being safe marijuana.
- 45:10We do know marijuana addiction occurs.
- 45:13We do know that it's estimated about a third of the people who
- 45:15use marijuana may actually have marijuana use disorder.
- 45:18If they start using marijuana before the age of eighteen,
- 45:21they're somewhere between four to seven times more likely to develop MUD,
- 45:25marijuana use disorder, or cannabis use disorder,
- 45:29the terms that's used.
- 45:30The withdrawal symptoms are very similar to a lot of other things.
- 45:33They're irritable, mood problems,
- 45:36sleep difficulties, appetite goes down,
- 45:39they have the cravings, the restlessness.
- 45:41The ~ symptoms usually peak first week after the last dose,
- 45:45and typically last about two weeks.
- 45:48One of the things that there's been studies is when people have developed this.
- 45:52And in the animal studies, we do see that there is a reduction in
- 45:56the production and sensitivity of endocannabinoid receptors.
- 45:59So there's some downregulation.
- 46:00And again, the studies are showing there's significant amounts.
- 46:04In 2015, it was estimated four million people in the U.S.
- 46:08met the criteria for MUD. 138,000 voluntarily seek treatment.
- 46:14And that was for marijuana use disorder alone,
- 46:17not with other drugs.
- 46:18This is a symptom that showed up that many people have not heard of before.
- 46:23It's called scromiting. And the scromiting term comes from the term
- 46:27of a combination of screaming and vomiting.
- 46:29So heavy marijuana use typically is we're looking at multiple times
- 46:34a week for longer than a year,
- 46:36puts them at a higher risk. And what happens is this produces a hyperemesis,
- 46:40so they're throwing up and it's extremely painful.
- 46:43So what happens is they scream,
- 46:45and that's where the term scromiting comes from.
- 46:47So it's dose-related. When the marijuana use stops,
- 46:50it goes away. What we looked at again is in the 90s,
- 46:54we're looking at per joint one to three milligrams of THC.
- 46:57Currently we're about 18 milligrams per joint.
- 47:00~ CBD doesn't appear to cause this,
- 47:03but this has gained some publicity over the last ~ few years.
- 47:07It's interesting and ironic that marijuana is often promoted as a antiemetic.
- 47:11Does marijuana affect your brain?
- 47:12~ These are some spec scans. I always like showing these to the students.
- 47:17So on your right is a normal brain,
- 47:19and on your left is a 16-year-old that has been using marijuana for two years.
- 47:26Those are not physical holes, those are areas of decreased function.
- 47:31So pretty significant effects there.
- 47:34Another one, this one you got an eighteen year old using four times a week,
- 47:37three-year history.
- 47:39And then you can see various other ones,
- 47:41scans that are showing this over a period of time.
- 47:43So with younger patients and students,
- 47:46I've found that spec scans are good.
- 47:49Now getting back to there was a question,
- 47:51are prescribers actually prepared?
- 47:53They surveyed medical school deans,
- 47:56residents, looked at medical school curriculum back in 2017.
- 48:00They found 75% of the medical school deans said their graduates were not at
- 48:04all prepared or only slightly prepared to answer questions about medical marijuana.
- 48:09And yet this is being promoted.
- 48:1094% of the medical school deans reported graduates are not at
- 48:14all prepared or slightly prepared to prescribe marijuana.
- 48:18And that's what I've seen specifically in giving programs to ~ physicians.
- 48:24When you look at do these things really work,
- 48:27in 2017, the National Academy of Sciences, Engineering,
- 48:30and Medicine issued a report and stated "there is conclusive
- 48:34or substantial evidence for medical marijuana being effective for chronic pain,
- 48:39for chemotherapy-induced nausea and vomiting,
- 48:42and for spasticity associated with MS." Their statements said "the benefits must
- 48:46be balanced with the risk," and we've talked about those
- 48:49previously. In another article by JAMA,
- 48:53they make the statement "insufficient evidence exists for the
- 48:56use of medical cannabis for which its use is advocated.
- 48:59Despite the lack of evidence, various state governments have recommended cannabis
- 49:03for the management of more than 50 medical conditions.
- 49:05Cannabis is useful for some conditions,
- 49:07but patients who might benefit may not get appropriate treatment because
- 49:11of sufficient
- 49:12awareness regarding the evidence supporting its use or confusion from federal law."
- 49:17So there's real concerns and there is a lot,
- 49:19this is sort of the pseudoscience of where individuals are basically saying that
- 49:24it's not as good as what a lot of people are concerned with.
- 49:27When we're dealing with elderly,
- 49:29we have to be careful for falls,
- 49:31especially if they're using any other CNS drug or any blood pressure medications.
- 49:36We don't really have a control over what the patient is getting in dispensaries.
- 49:39And a lot of times patients actually don't know how much THC or
- 49:44CBD that they actually are on.
- 49:46And these are important things for us to know.
- 49:48Now I picked a few slides dealing from what we saw in Alabama,
- 49:52but the requirements in Alabama is prescribers have to pass an exam,
- 49:56they have to verify the patient has a qualifying condition,
- 50:00and conventional therapy or medical treatment has failed.
- 50:03And then this is a list of the qualifying conditions that it can be used for.
- 50:07So I won't read through those,
- 50:08but you've got them there in front of you.
- 50:10Patient has to show proof of Alabama residency.
- 50:12They have to have a medical marijuana card.
- 50:14That's going to cost about $65.
- 50:16And they have to enter into a statewide cannabis registry.
- 50:19If they're a minor, under 19 years old,
- 50:21goes through the same process.
- 50:23They have to have a designated caregiver,
- 50:25and both caregiver and the minor must be Alabama residents and registered.
- 50:29So a lot of red tape to go through it.
- 50:31They recognize recreational marijuana is a significant threat,
- 50:35and there are significant penalties.
- 50:37~ Basically, they limit the possession of 70 doses,
- 50:43daily doses,
- 50:45even if you've got a medical marijuana license,
- 50:47and jail is the consequence. This can be prescribed for up to twelve months;
- 50:52the dosage has to be 50 milligrams or lower.
- 50:55But after it's determined that it's not working or the patient is terminally ill,
- 50:59they can increase it to 75 milligrams.
- 51:02And when they go above 75, then the patient's driver license has to be suspended.
- 51:07They have specific
- 51:09forms that are available. And one of the things,
- 51:12a concern about ~ the edibles,
- 51:14they're non-sugar-coated gelatinous cube,
- 51:17cuboid, or lozenge. And actually I think the state has only one flavor
- 51:22of which it can be dispensed in.
- 51:24They do not allow it to be smoked or vaped,
- 51:26cannot be sugar-coated, cannot put in food,
- 51:29cannot be consumed or sold as a raw plant.
- 51:31And ~ right now I think Alabama was looking at peach being the official flavor.
- 51:36So here's a big issue we run into,
- 51:38and I've run into some law cases that this has come in about.
- 51:40If you're on an anti-anxiety med like Xanax,
- 51:43your employer will typically let you work.
- 51:45But the marijuana laws in several states basically do not require
- 51:51the employer to let you work if you're using medical marijuana.
- 51:54They can basically refuse to hire you or they can fire you.
- 51:59And they may actually create a drug testing policy against medical marijuana.
- 52:04So ~ they require employees to notify them if they start using the drug.
- 52:08Employers aren't required to pay for the drug through medical insurance,
- 52:12and they can deny workers' comp.
- 52:14That's one of the big things that I've seen that has popped
- 52:17up with medical marijuana. Can't sue the employer.
- 52:20If fired, they could be considered having been discharged from
- 52:22job because of misconduct. So it can create some big issues.
- 52:26In Alabama, I think what's interesting is they have not created the registry.
- 52:31They have not established dispensaries.
- 52:32So even though it's legal, there's no way for them to actually get it.
- 52:36As I mentioned before, there are some studies that have suggested that people taking
- 52:42~ commercially available
- 52:44~ CBD or hemp seed oil can actually test positive in the workplace drug test.
- 52:49So that can be a big issue that may have to be addressed.
- 52:54So sort of getting here toward the end,
- 52:56because I'm running out of time,
- 52:57I've actually gone over 'em: Cannabinoids do have medical value,
- 53:01okay? They are not necessarily superior to existing medications,
- 53:06they don't cure everything.
- 53:07They are natural substances, but they do have side effects,
- 53:10just like everything else. And many of the cannabinoids have very similar effects.
- 53:15There's some differences, but there may be some different effects there.
- 53:18Medical cannabis obtained from state-approved sources is required
- 53:22to have consistent amounts of cannabinoids.
- 53:24~ Theoretically, yes, but we've already seen that that may not necessarily
- 53:29be the case. Patients aren't protected if they have a marijuana card.
- 53:33And the clinician, unless they meet the criteria for the state,
- 53:38can't just write them a prescription for cannabis.
- 53:40So these are things that we're coming across with.
- 53:43And then my last slide here is basically in 2019,
- 53:47we had a 52-year-old man who ~ basically used liquid marijuana at home,
- 53:5210 to 20 times the dose, and ended up dying.
- 53:55So we have had a death due to
- 53:57marijuana. I appreciate your attention.
- 53:59We may have a moment or so, Phil,
- 54:01for a couple of quick questions.
- 54:03I do have questions in the Q&A.
- 54:05How to distinguish the quality of CBD and how to trust licensed dispensaries?
- 54:10Okay, so the quality of CBD, that is a big concern right now.
- 54:14~ Because other than the epidiolex,
- 54:17we don't have anything. All of these are supplements,
- 54:19so you're really left up to what the supplement company basically says it is.
- 54:26Other than that, you know, sometimes when I have a case that somebody's taken
- 54:30the CBD, ~ what I've done is ask them if they want to analyze it.
- 54:35But right now, the FDA will, if they find out there's a difference,
- 54:39the FDA may pull it out, but it's more reaction and it's not...
- 54:42~ they're not required to demonstrate purity with regard to that.
- 54:47I want to express my deep thanks to you,
- 54:49Doctor, for being here ~ and for ~ offering something that obviously is
- 54:55of such high interest to so many people.
- 54:58And thanks to ~ the program here in
- 55:02Clinical Psychopharmacology that allows people that have a doctorate
- 55:06in clinical psych, either PsyD or PhD,
- 55:09~ if your state allows for prescriptive privileges,
- 55:13it certainly is a way to move towards that.
- 55:17But even if you don't live in that state,
- 55:20as Dr. Tackett talked about, it's important for people to understand about
- 55:25the medications and the substances that people are taking.
- 55:29So thank you so much, Dr. Tackett,
- 55:31thank you all for being here and thank you for caring
- 55:33so much about psychopharmacology and prescriptive rights.
- 55:38I did see one last question up here:
- 55:40the impact of women use on CBD THC from street and licensed dispensaries.
- 55:45That is a question with regard to ~ the reproductive health;
- 55:49has really not been addressed really well.
- 55:53~ Our biggest concern with regard to ~ reproductive health,
- 55:57we do know marijuana itself can affect the tissues.
- 56:01We know that it can affect sperm.
- 56:04We know that it potentially can interrupt
- 56:07some endocrine issues depending on the dose.
- 56:08And I would say that a lot of people,
- 56:11~ the edibles people are getting,
- 56:14and again, a lot of patients don't think anything of it since they purchased
- 56:17it ~ from a legitimate source.
- 56:20But there is such a high variability.
- 56:23What I have seen is people in the healthcare industry,
- 56:26people in education, and people in law enforcement are
- 56:32at the highest risk for
- 56:34potentially failing a drug test.
- 56:36I see a lot of nurses, for example,
- 56:38use ~ CBD products to help them sleep and they say it's helpful for their stress.
- 56:43And I've warned several of them,
- 56:46and I've had a couple of my students that have failed drug tests
- 56:50in the hospital systems. And the hospitals basically are telling them they're
- 56:55not going to work in a hospital anymore.
- 56:56And one of my students in particular,
- 56:58that had been using the CBD product,
- 57:01he was bipolar and ~ said it was really very calming for him and he was using
- 57:06it on the weekends. He failed his drug test.
- 57:08We don't know if the CBD product happened to have THC in it or what.
- 57:12Nevertheless, is that the hospital system,
- 57:15we had to move him out and he wanted to work in that hospital system and that
- 57:20is not going to be possible. Some of these hospital systems have said carte blanc,
- 57:23No.
- 57:24I've found that with education system,
- 57:26too. ~ So it is a concern, and one of the things I've been trying to tell people,
- 57:30clinicians, if you're prescribing,
- 57:32your patients need to be aware of that.
- 57:33And if you are dealing with a patient,
- 57:35sometimes they haven't been told that,
- 57:37and it's wise. And I have found that sometimes patients are reluctant
- 57:41to tell you that they are taking a CBD or a THC product,
- 57:45but it is very important ~ for us to know so we can inform them.
- 57:50With that,
- 57:51~ I thank again all of you. I hope you have a wonderful night.
- 57:54Thank you again for attending.